243 related articles for article (PubMed ID: 26229439)
1. Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
Revathi R; Venkatesha Perumal R; Pai KS; Arunkumar G; Sriram D; Kini SG
Drug Des Devel Ther; 2015; 9():3779-87. PubMed ID: 26229439
[TBL] [Abstract][Full Text] [Related]
2. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
[TBL] [Abstract][Full Text] [Related]
3. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
5. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
[TBL] [Abstract][Full Text] [Related]
6. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
[TBL] [Abstract][Full Text] [Related]
8. Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents.
Tawari NR; Bag S; Raju A; Lele AC; Bairwa R; Ray MK; Rajan MG; Nawale LU; Sarkar D; Degani MS
Future Med Chem; 2015; 7(8):979-88. PubMed ID: 26062396
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
[TBL] [Abstract][Full Text] [Related]
11. Rational drug design based synthesis of novel arylquinolines as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Ray M; Rajan MG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6097-105. PubMed ID: 24095091
[TBL] [Abstract][Full Text] [Related]
12. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
Khan IH; Patel NB; Patel VM
Curr Comput Aided Drug Des; 2018; 14(4):269-283. PubMed ID: 29766819
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
[TBL] [Abstract][Full Text] [Related]
16. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
Ramprasad J; Nayak N; Dalimba U
Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Kumar G; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
